The pleckstrin DEP domain structure DEP domains are divergent in sequence. Using multiple sequence alignments and phylogenetic tree reconstructions, we found at least six subfamilies of DEP domains. We selected Pleckstrin, the major substrate of PKC in platelets, for further structural research. We found that the Pleck-DEP fold contains an additional short helix !4 inserted in the "4-"5 loop with respect to other DEP structures. This helix exhibits increased backbone mobility, as shown by NMR relaxation measurements, and may be involved in protein-protein interactions. (Civera et al, 2005.) 
The pleckstrin DEP domain structure DEP domains are divergent in sequence. Using multiple sequence alignments and phylogenetic tree reconstructions, we found at least six subfamilies of DEP domains. We selected Pleckstrin, the major substrate of PKC in platelets, for further structural research. We found that the Pleck-DEP fold contains an additional short helix !4 inserted in the "4-"5 loop with respect to other DEP structures. This helix exhibits increased backbone mobility, as shown by NMR relaxation measurements, and may be involved in protein-protein interactions. (Civera et al, 2005.) Unraveling the protein-protein interaction scenario during splicing: implication of FF domains To clarify the functional roles of other domains present in the Prp40 splicing factor, we studied the structure and ligand preferences of its fist FF domain. Our results revealed that not all FF domains in Prp40 are functionally equivalent. We proposed that FF domains have at least two distinct interaction surfaces, which have evolved to recognise distinct binding motifs. This is an ongoing project since we are now examining the role of other divergent FF domains present in Prp40 and in CA150. (Gasch et al, 2006.) 
Phosphorylation of the Itch WW domain does not affect its 3D structure
Recent evidence shows that the ubiquitin ligase Itch can be efficiently phosphorylated in vivo at several positions. Since domain phosphorylation is quite unusual (it normally occurs at flexible linkers that connect domains), we sought to clarify whether the Itch WW domain maintains its fold when phosphorylated. We expressed the wild-type domain and Dr. Miriam Royo's group at the PCB synthesised the phosphorylated variants. Our structural work supports the view that in the three cases examined (wild-type and phosphorylated mutants) the WW structure is maintained, thereby opening up the possibility of regulating ligand binding upon domain phosphorylation. (Shaw et al, 2005.) 
Regulation of ligand binding by serine/threonine phosphorylation of WW domains
Using NMR we have studied the role of phosphorylation as a regulatory mechanism for the interaction between the E3 ubiquitin-ligase ItchWW3 domain and two PPxY motifs of one of its targets, the Epstein-Barr virus latent membrane protein 2A. While ligand phosphorylation only diminishes binding, domain phosphorylation at T30 abrogates it. We show that two Itch WW domains can be phosphorylated at this
The main focus of our research is the study of protein-protein interactions at an atomic level, with the objective to provide 3D structures that contribute to a better description of biological processes. We apply multidimensional nuclear magnetic resonance (NMR) spectroscopy in conjunction with other biophysical and biomolecular techniques in order to characterise the properties of the proteins and ligands under study. Our activities are therefore centered not only on the structural determination of proteins and complexes but also on deciphering the mechanisms that contribute to the definition and maintenance of a given fold, or to the control of a given interaction. Our research involves the efficient coordination of the following: a) A wet lab for protein cloning, expression and purification aimed at obtaining labelled protein samples required for NMR experiments.
We have recently incorporated small scale solid-phase peptide synthesis, which allows the preparation of peptides required for ligand binding studies at a low cost and in a short time. b) Set-up of NMR experiments at the spectrometer. c) Internal computational facility, which allows the processing of NMR data, and the assignation, calculation and analysis of structures. We have also installed our own computational grid in the lab to process parallel jobs. d) Development of software packages, which cover data processing and assignment to structure calculation, in order to facilitate the processes of structural determination by NMR. In addition, several programmes and protocols developed in our lab are available free of charge and can be either directly downloaded from our group web page, or sent upon request. 
Biomolecular NMR spectroscopy

New ligand binding modes in WW domains
We have recently found that the second domain of the transcription factor CA150 binds a new motif, which we named PPLIPP, in at least two distinct modes, both of which use a newly identified cavity known as the XP2 groove. In collaboration with Dr. Carles Suñe (CSIC-Madrid), we are currently studying the interactions of this domain with other ligands containing variable PPxxxPP motifs (manuscript in preparation).
Software development: automatic assignment of NMR data
The main bottleneck of the NMR process still lies at the data-analysis step, called resonance assignment. We have developed a software package that combines peak-picking and assignment processes, thereby improving performance in both tasks and drastically reducing user intervention and assigning not only protein backbone but also carbon side-chains. At present, we are working on the automated assignment of protons. (Martin-Malpartida P and Macias MJ; in preparation).
Figure 1. Titration experiments for the phosphorylated domain variants. A.
Superimposition of pT30 (phosphorylated T30) TOCSY spectrum in the free (black), and after the addition of 7 times excess of PY peptide (magenta). Some residues located in the domain's binding site are labelled for clarity. Even in the presence of high excess of peptide, no changes in the domain resonances are observed. B. Identical region of the TOCSY spectrum displayed in A but for the pS16 variant. In this case, the addition of a 3:1 peptide excess induces changes very similar to the ones observed for the wild type. Again, the reference is shown in black while the complex is displayed in magenta. Some residues in the binding site are also labelled. The inset displays the alpha and amide chemical shift differences calculated for the 3:1 complex with respect to the free pS16 chemical shifts. C. Surface and cartoon representation of the pT30 structure calculated from the NOESY experiment of ItchWW3 pT30 variant showing that the phosphorylation of T30 partially reduces the XP binding cavity, used to interact with the ligand prolines. 
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